| 查看: 877 | 回复: 10 | |||
[交流]
邀稿 (糖尿病足相关)(Frontiers in Pharmacology,中科院二区top )
|
|||
|
最近受邀搞一个特刊,有关于糖尿病足,具体内容如下: 期刊名:Frontiers in Pharmacology (中科院分区:二区top) 切记:OA期刊 (文章接受后需要交版面费) 内容:与糖尿病足相关(研究,综述,临床研究报告等均可) 欢迎大家来搞。 Diabetes is a complex metabolic disease that affects more than 340 million individuals worldwide. Around 20% of these patients develop diabetic wounds. Diabetic foot ulcers (DFUs) are a common complication of diabetes that are recalcitrant to healing due to persistent inflammation. Only one FDA-approved medicine, becaplermin, is used to treat DFUs, but it is not the first-line therapy because of its low efficacy and higher risk of cancer and mortality. The absence of effective and safe treatment has necessitated the development of more effective medications or procedures. The mechanism underlying this process, however, remains unknown, prompting further research into diabetic foot ulcer etiology. The development of diabetic wounds is a serious complication for patients with diabetes. Peripheral neuropathy, foot deformity, external trauma, peripheral vascular disease, and peripheral oedema are just a few of the contributing elements that lead to foot ulcers in diabetic individuals. Infection is widespread in DFUs, resulting in the patient’s protracted hospitalization and psychological issues. A better understanding of pathogenic variables can aid in the development of innovative treatments for poor healing. The aim of this Research Topic is to provide a forum focusing on the pathogenesis of DFUs. An understanding of the critical pathways involved will guide future therapies against DFUs. Studies investigating contributing factors of diabetic foot in vitro and in vivo, as well as human clinical samples, are encouraged to accelerate the development of innovative therapies and drugs. Manuscripts relating to DFUs focusing on, but are not limited to, the following topics are invited in this Research Topic: • Identification of new biological pathways and mechanisms • Clinical data sets • Therapeutic regimens for the management of DFUs |
» 猜你喜欢
一个化合物的合成路线:CAS:367929-02-0 名称:8β-乙烯基雌二醇
已经有4人回复
太白金星有点烦
已经有3人回复
中国地质大学(北京)博士招生补录,数理学院材料科学与工程专业和材料与化工专业
已经有3人回复
河北省自然基金
已经有8人回复
收到国自然专家邀请后几年才会有本子送过来评
已经有3人回复
考博
已经有3人回复
有没有快的中文核心比较快录用的,纳米材料光催化
已经有4人回复
本人42,博士刚毕业,现在找不到工作,怎么办?:(
已经有21人回复
有人投过CCC中国控制会议吗?
已经有3人回复
3,4-二羟基苯乙酮如何纯化?
已经有5人回复
» 抢金币啦!回帖就可以得到:
山海自有归期,风雨自有相逢(武汉)
+1/263
湖北人在北京
+1/263
东南大学废弃碳资源利用团队(杰青/海优团队)27级博士研究生和科研助理招生
+1/140
生命学部的面地青本子开始分发了么?
+1/88
精细结构常数α=1/137的素数起源:论文投稿审核历程(A202604-1381)
+1/75
大湾区大学张国强课题组招聘光催化方向博士后
+1/31
南方医科大学肿瘤表观遗传学课题组博士后招聘
+1/30
海南大学药学院黄玲教授2026招收药理(神经药理)方向博士生一名
+1/28
大湾区大学张国强课题组招聘光催化方向博士后
+1/27
大甲方公司招聘临床药理/DMPK研究员
+1/24
A口国自然
+1/16
宁夏大学2026博士招生
+1/7
上海交通大学复合材料研究所诚聘科研助理
+1/6
科研服务:病毒包装、细胞系构建、蛋白表达、基因编辑
+1/5
中国药科大学陈达威教授2026招收药理学学术型博士生一名(截止日期5月12日)
+1/4
中国林科院林业研究所 ,林业专业博士名额1个,截止报名日期2026年4月29日
+1/3
广东工业大学机电工程学院高伟教授招收2026级博士生
+1/3
深圳大学材料学院“智能分子材料团队”招聘博士后(连续流微反应器方向优先)
+1/2
美国博士后招聘,代谢的转录调控方向,干+湿结合实验室,欢迎Email咨询。
+1/2
中国科学院苏州纳米所院士团队招聘
+1/1
4楼2022-08-10 21:54:19
10楼2022-08-10 22:31:47
简单回复
tzynew2楼
2022-08-10 21:49
回复
basin_2011(金币+1): 谢谢参与
o 发自小木虫Android客户端
飞雪天刘3楼
2022-08-10 21:53
回复
basin_2011(金币+1): 谢谢参与
。 发自小木虫Android客户端
bjdxyxy5楼
2022-08-10 21:55
回复
basin_2011(金币+1): 谢谢参与
。 发自小木虫Android客户端
nono20096楼
2022-08-10 21:57
回复
basin_2011(金币+1): 谢谢参与
·
2022-08-10 21:59
回复
yuekong8楼
2022-08-10 22:12
回复
人间失落9楼
2022-08-10 22:21
回复
basin_2011(金币+1): 谢谢参与
! 发自小木虫Android客户端
miaojiabing11楼
2022-08-11 08:07
回复
basin_2011(金币+1): 谢谢参与












回复此楼